Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Cancer”

805 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 805 results

Testing effectiveness (Phase 2)Study completedNCT00410696
What this trial is testing

Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

Who this might be right for
Hematological NeoplasmsTumors
Armando Santoro, MD 80
Not applicableStudy completedNCT05236296
What this trial is testing

Emotion and Symptom-focused Engagement for Caregivers (EASE-CG) Pilot Study

Who this might be right for
Leukemia, Acute
University Health Network, Toronto 40
Not applicableUnknownNCT05963295
What this trial is testing

Toxoplasma Gondii Infection in Both Children and Adult Patients With Hematological Malignancies

Who this might be right for
Toxoplasmosis
Sohag University 50
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Large-scale testing (Phase 3)Study completedNCT02730299
What this trial is testing

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

Who this might be right for
Hematological MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)+4 more
Gamida Cell ltd 125
Large-scale testing (Phase 3)Study completedNCT00824993
What this trial is testing

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

Who this might be right for
Hematological Malignancies
M.D. Anderson Cancer Center 78
Early research (Phase 1)Ended earlyNCT03248479
What this trial is testing

Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies

Who this might be right for
Hematological Malignancies
Gilead Sciences 258
Very early researchUnknownNCT04700319
What this trial is testing

CAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological Malignancies

Who this might be right for
CAR
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 30
Not applicableStudy completedNCT01576653
What this trial is testing

Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL

Who this might be right for
Invasive Fungal InfectionHematological MalignancyReceipt of Solid Organ Transplant
Robert Krause, MD 100
Testing effectiveness (Phase 2)Study completedNCT00862719
What this trial is testing

Sitagliptin Umbilical Cord Blood Transplant Study

Who this might be right for
Leukemia, Myeloid, AcuteAcute Lymphoblastic LeukemiaMyelodysplasia+2 more
Indiana University 29
Not applicableStudy completedNCT00195533
What this trial is testing

Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients

Who this might be right for
Hematological MalignancyLeukemiaMyelodysplasia+3 more
Wyeth is now a wholly owned subsidiary of Pfizer 801
Early research (Phase 1)Temporarily pausedNCT04828174
What this trial is testing

Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies

Who this might be right for
Peripheral T Cell LymphomaAngioimmunoblastic T-cell LymphomaAnaplastic Lymphoma+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 9
Early research (Phase 1)Study completedNCT04283097
What this trial is testing

Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects

Who this might be right for
Hematological Malignancies
Kangpu Biopharmaceuticals, Ltd. 30
Not applicableUnknownNCT02791217
What this trial is testing

Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool

Who this might be right for
Lymphoma, B-CellFollicular LymphomaHodgkin Lymphoma+1 more
Assuta Medical Center 100
Early research (Phase 1)Study completedNCT03241550
What this trial is testing

Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

Who this might be right for
Hematological Malignancy
Astellas Pharma Global Development, Inc. 49
Post-approval studies (Phase 4)Looking for participantsNCT03844360
What this trial is testing

Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

Who this might be right for
Hematological Neoplasms
Wei Zhao 1,500
Not applicableLooking for participantsNCT05041140
What this trial is testing

Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment

Who this might be right for
PulmonaryPneumoniaHematopoietic System--Cancer
M.D. Anderson Cancer Center 25
Not applicableLooking for participantsNCT04645199
What this trial is testing

National Longitudinal Cohort of Hematological Diseases

Who this might be right for
Multiple MyelomaAcute Myeloid LeukemiaHemophilia+14 more
Institute of Hematology & Blood Diseases Hospital, China 2,300
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)UnknownNCT00129155
What this trial is testing

MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Hematological MalignanciesAllogeneic Transplantation
Hospices Civils de Lyon 30
Next Page